Q&A with Vadim Alexandre Head of Research at Northland Capital Partners

ImmuPharma PLC (LON:IMM) is the topic of conversation when Northland Capital Partners Head of Research Vadim Alexandre caught up with DirectorsTalk for an exclusive interview.

Click here